{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:31:06Z","timestamp":1793640666326,"version":"4.5.1"},"reference-count":17,"publisher":null,"issue":"9","license":[{"start":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T00:00:00Z","timestamp":1569024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>In the conclusion of the council of experts (list of participants see text) the following issues are discussed: regional specifics of diagnostics\u00a0and therapy of patients with ischemic heart disease (IHD) and \/ or peripheral arterial disease (PAD), methods of risk assessment in patients\u00a0with stable course of atherosclerotic disease, pathogenetic validity of simultaneous inhibition of coagulation and platelet thrombus formation,\u00a0as well as clinical significance of a novel therapeutic approach \u2013 combined use of rivaroxaban and acetylsalicylic acid (ASA). Possible problems\u00a0and ways to their solution at implementation in clinical practice of the novel scheme of antithrombotic therapy are presented. Importance\u00a0of multidisciplinary approach to management of patients with IHD and concomitant diseases is stressed. Experts have noted that after registration\u00a0of the corresponding indication therapy with rivaroxaban 2.5 mg twice daily and ASA 75\u2013100 mg once daily might be recommended\u00a0to majority of patients with atherosclerotic involvement of blood vessels. In real clinical practice prescription of this therapy is appropriate first\u00a0of all in patients with IHD and high risk of complications \u2013 with multifocal atherosclerosis, with history of myocardial infarction after stoppage\u00a0of dual antiplatelet therapy, \u2013 patients with concomitant diabetes, heart failure, and other prognosis worsening comorbid diseases. Experts express\u00a0hope that in the nearest time combined antithrombotic therapy will be included into corresponding national clinical recommendations.<\/jats:p>","DOI":"10.18087\/cardio.2019.9.n671","type":"journal-article","created":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T04:02:06Z","timestamp":1569038526000},"page":"97-100","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of Patients with Stable Manifestations of Atherosclerotic Vascular Disease: New Possibilities (Conclusion of the Council of Experts from November 16, 2018, Rostov-on-Don)"],"prefix":"10.68900","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1510-9204","authenticated-orcid":true,"given":"S. G.","family":"Kanorskii","sequence":"first","affiliation":[{"name":"Kuban State Medical University, Ministry of Health of the Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. A.","family":"Vasuk","sequence":"additional","affiliation":[{"name":"Moscow State University of Medicine and Dentistry named after A. I. Evdokimov"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Gridasova","sequence":"additional","affiliation":[{"name":"Rostov State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Kastanayan","sequence":"additional","affiliation":[{"name":"Rostov State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. P.","family":"Pagaev","sequence":"additional","affiliation":[{"name":"Medical Centre \u201cThe Clinic of Heart\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. I.","family":"Sadovoy","sequence":"additional","affiliation":[{"name":"Crimean Republican Clinical Hospital named after N. A. Semashko"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. V.","family":"Sidorov","sequence":"additional","affiliation":[{"name":"Rostov State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. P.","family":"Terent\u2019ev","sequence":"additional","affiliation":[{"name":"Rostov State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. B.","family":"Tuaeva","sequence":"additional","affiliation":[{"name":"Medical Centre \u201cThe Clinic of Heart\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. V.","family":"Frolov","sequence":"additional","affiliation":[{"name":"Volgograd State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. A.","family":"Khaisheva","sequence":"additional","affiliation":[{"name":"Rostov State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. V.","family":"Khripun","sequence":"additional","affiliation":[{"name":"Rostov State Medical University,\r\nRegional vascular center of Rostov regional clinical hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. I.","family":"Chesnikova","sequence":"additional","affiliation":[{"name":"Rostov State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":null,"published-online":{"date-parts":[[2019,9,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Steg PhG, Bhatt DL, Wilson PWF, D\u2019Agostino R, Ohman EM, R\u00f6ther J et al. One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis. JAMA. 2007;297(11):1197. DOI: 10.1001\/jama.297.11.1197","DOI":"10.1001\/jama.297.11.1197"},{"key":"ref2","unstructured":"Federal State Statistics Service. Modern problems of medical support of patients with cardiological diseases (according to the results of the project \u201cObtaining statistical information on the quality and availability of medical care for patients with cardiological profile\u201d). Analytical note."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a longterm perspective. European Heart Journal. 2015;36(19):1163\u201370. DOI: 10.1093\/eurheartj\/ehu505","DOI":"10.1093\/eurheartj\/ehu505"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Steg PhG, Bhatt DL, Wilson PWF, D\u2019Agostino R, Ohman EM, R\u00f6ther J et al. One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis. JAMA. 2007;297(11):1197. DOI: 10.1001\/jama.297.11.1197","DOI":"10.1001\/jama.297.11.1197"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Montalescot G, Sechtem W, Achenbach S, Andreotti F, Arden C, Budaj A et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal. 2013;34(38):2949\u20133003. DOI: 10.1093\/eurheartj\/eht296","DOI":"10.1093\/eurheartj\/eht296"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a longterm perspective. European Heart Journal. 2015;36(19):1163\u201370. DOI: 10.1093\/eurheartj\/ehu505","DOI":"10.1093\/eurheartj\/ehu505"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Aboyans V, Ricco J-B, Bartelink M-LEL, Bj\u00f6rck M, Brodmann M, Cohnert T et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). European Heart Journal. 2018;39(9):763\u2013816. DOI: 10.1093\/eurheartj\/ehx095","DOI":"10.1093\/eurheartj\/ehx095"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Montalescot G, Sechtem W, Achenbach S, Andreotti F, Arden C, Budaj A et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal. 2013;34(38):2949\u20133003. DOI: 10.1093\/eurheartj\/eht296","DOI":"10.1093\/eurheartj\/eht296"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. New England Journal of Medicine. 2017;377(14):1319\u201330. DOI: 10.1056\/NEJMoa1709118","DOI":"10.1056\/NEJMoa1709118"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Aboyans V, Ricco J-B, Bartelink M-LEL, Bj\u00f6rck M, Brodmann M, Cohnert T et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). European Heart Journal. 2018;39(9):763\u2013816. DOI: 10.1093\/eurheartj\/ehx095","DOI":"10.1093\/eurheartj\/ehx095"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Connolly SJ, Eikelboom JW, Bosch J, Dagenais G, Dyal L, Lanas F et al. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, doubleblind, placebo-controlled trial. The Lancet. 2018;391(10117):205\u201318. DOI: 10.1016\/S0140-6736(17)32458-3","DOI":"10.1016\/S0140-6736(17)32458-3"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. New England Journal of Medicine. 2017;377(14):1319\u201330. DOI: 10.1056\/NEJMoa1709118","DOI":"10.1056\/NEJMoa1709118"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. The Lancet. 2018;391(10117):219\u201329. DOI: 10.1016\/S0140-6736(17)32409-1","DOI":"10.1016\/S0140-6736(17)32409-1"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Connolly SJ, Eikelboom JW, Bosch J, Dagenais G, Dyal L, Lanas F et al. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, doubleblind, placebo-controlled trial. The Lancet. 2018;391(10117):205\u201318. DOI: 10.1016\/S0140-6736(17)32458-3","DOI":"10.1016\/S0140-6736(17)32458-3"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Jones WS, Patel MR, Dai D, Vemulapalli S, Subherwal S, Stafford J et al. High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease. American Heart Journal. 2013;165(5):809-815.e1. DOI: 10.1016\/j.ahj.2012.12.002","DOI":"10.1016\/j.ahj.2012.12.002"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. The Lancet. 2018;391(10117):219\u201329. DOI: 10.1016\/S0140-6736(17)32409-1","DOI":"10.1016\/S0140-6736(17)32409-1"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Jones WS, Patel MR, Dai D, Vemulapalli S, Subherwal S, Stafford J et al. High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease. American Heart Journal. 2013;165(5):809-815.e1. DOI: 10.1016\/j.ahj.2012.12.002","DOI":"10.1016\/j.ahj.2012.12.002"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/671\/507","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:16:39Z","timestamp":1793639799000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,21]]},"references-count":17,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,21]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2019.9.n671","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"value":"2412-5660","type":"electronic"},{"value":"0022-9040","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,21]]}}}